566 studies found for:    Open Studies | "Infant, Newborn, Diseases"
Show Display Options
Rank Status Study
21 Not yet recruiting Comparison Of Respiratory Support After Delivery on Infants Born Before 28 Weeks Gestational Age
Conditions: Respiration; Insufficient or Poor, Newborn;   Infant, Premature, Diseases
Interventions: Device: T-piece used for respiratory support (several manufacturers);   Device: New system used for respiratory support
22 Recruiting Puberty in Girls Followed for Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention: Procedure: Data collection
23 Recruiting 68Ga-NOTA-exendin-4 PET/CT for the Localization of Insulinoma and Diagnosis of Nesidioblastosis
Conditions: Insulinoma;   Nesidioblastosis
Intervention: Drug: 68Ga-NOTA-exendin-4
24 Recruiting Asthma With Hypersecretion-associated Gene for Cystic Fibrosis
Condition: Asthma
Intervention: Genetic: Asthma patients
25 Not yet recruiting Special Drug Use Investigation of Ciproxan Injection in Pediatrics
Conditions: Cystitis;   Pyelonephritis;   Cystic Fibrosis;   Anthrax
Intervention: Drug: Cipro (Ciprofloxacin, BAYQ3939)
26 Recruiting Video Game Exercise Effectiveness of a Domiciliary Pulmonary Rehabilitation Program in Cystic Fibrosis Patients
Condition: Cystic Fibrosis
Intervention: Other: Nintendo Wii exercise program
27 Not yet recruiting Extracorporeal Lung Assist Device in Acute Lung Impairment
Condition: Acute Respiratory Distress Syndrome
Interventions: Procedure: iLA activve treatment;   Procedure: Control group
28 Recruiting Analysis T Cells Response for Identification of Aspergillus Bronchitis With Cystic Fibrosis Patients
Conditions: Cystic Fibrosis Patient;   Patient Without Treatment Against A.Fumigatus
Intervention: Other: T specific response for diagnostic of aspergillus bronchitis
29 Not yet recruiting Epidemiology and Treatment of Small-colony Variant Staphylococcus Aureus in Cystic Fibrosis
Conditions: Cystic Fibrosis;   MRSA
Intervention: Drug: Rifampin
30 Recruiting Monitoring in Intensive Care Unit of Neuromuscular Blocking Agents (NMBA) Used for Acute Respiratory Distress Syndrome (ARDS) After Cardiothoracic Surgery
Condition: Acute Respiratory Distress Syndrome
Intervention: Other: Train of four monitoring
31 Recruiting A Role for RAGE/TXNIP/Inflammasome Axis in Alveolar Macrophage Activation During ARDS (RIAMA): a Proof-of-concept Clinical Study
Conditions: Acute Respiratory Distress Syndrome;   Mechanical Ventilation
Intervention: Other: RAGE TXNIP Inflammasome axis
32 Recruiting Comparison of Amikacin Lung Delivery With Two Nebulizers
Conditions: Healthy;   Cystic Fibrosis
Interventions: Device: Nebulizer 1;   Device: Nebulizer 2
33 Not yet recruiting 6 Minute Walk Test in Cystic Fibrosis
Condition: Cystic Fibrosis
Intervention: Other: 6-minute walk test
34 Recruiting Combining Restrictive Guidelines and a NIRS SCORE to Decrease RBC Transfusions
Condition: Anemia of Prematurity (AOP)
Interventions: Other: Restrictive transfusions based on SCOR assessment;   Other: Liberal transfusions
35 Recruiting Evaluation of Nebulization and Positive Expiratory Pressure Combination
Condition: Cystic Fibrosis
Interventions: Device: Positive expiratory pressure;   Drug: Amikacine nebulization
36 Available Study of the Use of [18F]-DOPA in Hyperinsulinemic Hypoglycemia
Conditions: Hyperinsulinemic Hypoglycemia, Persistent;   Congenital Hyperinsulinism;   Persistent Hyperinsulinemic Hypoglycemia of Infancy (PHHI)
Intervention: Drug: 18 F-DOPA
37 Recruiting Dose Escalation Study of QR-010 in Homozygous ΔF508 Cystic Fibrosis Patients
Condition: Cystic Fibrosis
Interventions: Drug: QR-010;   Drug: Placebo
38 Recruiting Genetics of Pediatric-Onset Motor Neuron and Neuromuscular Diseases
Conditions: Spinal Muscular Atrophy;   Charcot-Marie-Tooth Disease;   Muscular Dystrophy;   Spinal Muscular Atrophy With Respiratory Distress 1;   Amyotrophic Lateral Sclerosis;   Motor Neuron Disease;   Neuromuscular Disease;   Peroneal Muscular Atrophy;   Fragile X Syndrome
Intervention: Other: sample collection
39 Not yet recruiting Trial To Assess The Safety And Tolerability Of Lucinactant For Inhalation In Preterm Neonates 26 to 28 Weeks PMA
Condition: Respiratory Distress Syndrome
Interventions: Drug: Lucinactant for inhalation;   Device: nCPAP alone
40 Not yet recruiting Safety of Furosemide in Premature Infants at Risk of Bronchopulmonary Dysplasia (BPD)
Condition: Bronchopulmonary Dysplasia
Interventions: Drug: Furosemide Cohort 1;   Drug: Furosemide Cohort 2;   Drug: Furosemide Cohort 3;   Other: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years